Specify a stock or a cryptocurrency in the search bar to get a summary
Quest Diagnostics Incorporated
DGXQuest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey. Address: 500 Plaza Drive, Secaucus, NJ, United States, 07094
Analytics
WallStreet Target Price
168.85 USDP/E ratio
20.8824Dividend Yield
1.92 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures DGX
Dividend Analytics DGX
Dividend growth over 5 years
43 %Continuous growth
12 yearsPayout Ratio 5 years average
37 %Dividend History DGX
Stock Valuation DGX
Financials DGX
Results | 2019 | Dynamics |